SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+35.99%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.46B
AUM Growth
+$1.46B
(+38%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
8.68%
Top 10 Holdings %
Top 10 Hldgs %
62.29%
Holding
88
New
21
Increased
19
Reduced
9
Closed
13
Top Buys
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$34.1M |
| 2 |
Gilead Sciences
GILD
|
$31M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$26.9M |
| 4 |
Eli Lilly
LLY
|
$24.4M |
| 5 |
AbbVie
ABBV
|
$19.8M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$21.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$20.4M |
| 4 |
Biogen
BIIB
|
$16.7M |
| 5 |
Merus
MRUS
|
$10.5M |
Sector Composition
| 1 | Healthcare | 98.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Heron Therapeutics
HRTX
$204M
| – | – |
-481,608
| Closed | -$5.65M |
|
77
Iovance Biotherapeutics
IOVA
$800M
| – | – |
0
| – | – |
|
78
Iterum Therapeutics
ITRM
$28.1M
| – | – |
-115,101
| Closed | -$4.68M |
|
79
NovoCure
NVCR
$1.35B
| – | – |
0
| – | – |
|
80
iShares S&P 100 ETF
OEF
$22.1B
| – | – |
0
| – | – |
|
81
Pfizer
PFE
$141B
| – | – |
0
| – | – |
|
82
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
83
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
84
SPDR NYSE Technology ETF
XNTK
$1.24B
| – | – |
0
| – | – |
|
|
ALXN
85
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-307,300
| Closed | -$27.6M |
|
|
ZGNX
86
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-32,983
| Closed | -$816K |
|